A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis.

Source:http://linkedlifedata.com/resource/pubmed/id/18253120

Br. J. Cancer 2008 Feb 26 98 4 720-7

Download in:

View as

Triples

General Info

PMID
18253120